Immuron Director Resignation
03 mai 2024 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen...
Galapagos rapporteert financiële resultaten voor het eerste kwartaal 2024
02 mai 2024 16h01 HE
|
Galapagos NV
Vooruitgang met potentiële best-in-class R&D pijplijn van celtherapie en kleine moleculen, met vier klinische assets en >15 onderzoeksprogramma's in oncologie en immunologie Overeenkomsten...
Galapagos reports first quarter 2024 financial results
02 mai 2024 16h01 HE
|
Galapagos NV
Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with...
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02 mai 2024 09h15 HE
|
Virios Therapeutics
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat...
IMCD reports EBITA of EUR 127 million in the first three months of 2024
26 avr. 2024 01h00 HE
|
IMCD N.V.
Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first...
Immunocore announces upcoming presentation and posters at ASCO 2024
24 avr. 2024 10h00 HE
|
Immunocore Holdings plc
Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be...
IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
24 avr. 2024 01h00 HE
|
IMCD N.V.
ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to...
Immuron to host Live Virtual Event
15 avr. 2024 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our...
Revival Gold Agrees to Acquire Ensign Minerals and Announces Concurrent C$7 Million Equity Financing
10 avr. 2024 07h30 HE
|
Revival Gold Inc.
Creating One of the Largest Gold Development Companies in the United States with an Enhanced Platform for Heap Leach Gold Production from Low CapEx Brownfield Sites NOT FOR DISTRIBUTION TO UNITED...
Immuron Travelan® sales continued strong growth
10 avr. 2024 06h00 HE
|
Immuron Limited
Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcpMar 2024 Quarter AUD$1.3 million up 51% on pcp and 75% on last quarter ...